Case Note & Summary
The petitioners, Sandoz Private Limited and Lupin Limited, are pharmaceutical companies engaged in the manufacture and export of pharmaceutical products. They applied for Advance Authorization under the Foreign Trade Policy to import inputs duty-free for export production. The respondents, Union of India and others, denied the benefit on the ground that the petitioners failed to fulfill the condition of minimum value addition of 50% as per Para 4.1.5 of the Foreign Trade Policy. The petitioners challenged the denial by filing writ petitions before the Bombay High Court. The court examined the provisions of the Foreign Trade Policy and found that the condition of minimum value addition is not applicable to the products in question as they are not covered by the list of items requiring such condition. The court also noted that the impugned orders were passed without affording an opportunity of hearing to the petitioners, violating principles of natural justice. The court allowed the petitions, quashed the impugned orders, and directed the respondents to reconsider the applications in accordance with law.
Headnote
A) Foreign Trade Policy - Advance Authorization Scheme - Minimum Value Addition - Condition Precedent - The condition of minimum value addition of 50% under Para 4.1.5 of the Foreign Trade Policy is not applicable to the product in question as the product is not covered by the list of items requiring such condition. The denial of benefits on this ground is unsustainable. (Paras 1-33) B) Administrative Law - Natural Justice - Opportunity of Hearing - The impugned orders were passed without affording an opportunity of hearing to the petitioners, which is violative of principles of natural justice. (Paras 20-25) C) Interpretation of Statutes - Foreign Trade Policy - Condition Precedent - The condition of minimum value addition is a condition precedent for availing the benefit of Advance Authorization, but it must be specifically applicable to the product. In the absence of such applicability, the condition cannot be imposed. (Paras 26-30)
Issue of Consideration
Whether the denial of Advance Authorization benefits to the petitioners for export of pharmaceutical products on the ground of non-fulfillment of the condition of minimum value addition of 50% as per Para 4.1.5 of the Foreign Trade Policy is legally sustainable.
Final Decision
The court allowed the writ petitions, quashed the impugned orders, and directed the respondents to reconsider the applications in accordance with law, after affording an opportunity of hearing to the petitioners.
Law Points
- Interpretation of Foreign Trade Policy
- Advance Authorization Scheme
- Minimum Value Addition
- Condition Precedent
- Export Obligation
- Special Economic Zone
